Skip to main content
SpringerLink
Log in

Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency

  • Practice Point
  • Published:

From Nature Clinical Practice Endocrinology & Metabolism

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Leal A et al. (2002) A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test. Clin Endocrinol (Oxf) 57: 377–384

    Article  CAS  Google Scholar 

  2. Mahajan T and Lightman SL (2000) A simple test for growth hormone deficiency in adults. J Clin Endocrinol Metab 85: 1473–1476

    Article  CAS  Google Scholar 

  3. Gasperi M et al. (1999) Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test. J Clin Endocrinol Metab 84: 2633–2637

    CAS  PubMed  Google Scholar 

  4. Bowers CY (1998) Synergistic release of growth hormone by GHRP and GHRH: scope and implication. In Growth Hormone Secretagogues, 1–25 (Eds Bercu B and Walker R) New York: Marcel Dekker

    Google Scholar 

  5. Muccioli G et al. (2007) Heterogeneity of ghrelin/growth hormone secretagogue receptors. Toward the understanding of the molecular identity of novel ghrelin/GHS receptors. Neuroendocrinology [doi:10.1159/000105141]

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. CY Bowers is an Emeritus Professor at Tulane University Health Sciences Center, New Orleans, LA, USA;,

    Cyril Y Bowers

  2. GR Merriam is a Professor of Medicine at the University of Washington, Seattle, WA, USA;,

    George R Merriam

  3. JD Veldhuis is a Professor of Medicine at the Mayo Medical and Graduate Schools of Medicine, Rochester, MN, USA.,

    Johannes D Veldhuis

Authors
  1. Cyril Y Bowers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George R Merriam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Johannes D Veldhuis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cyril Y Bowers.

Ethics declarations

Competing interests

GR Merriam receives grant support from Ardana Bioscience and is a consultant to Elixir. The other authors declared no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bowers, C., Merriam, G. & Veldhuis, J. Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency. Nat Rev Endocrinol 4, 68–69 (2008). https://doi.org/10.1038/ncpendmet0679

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0679

  • Springer Nature Limited

This article is cited by

Search

Navigation